What is Igenbio?
Igenbio, Inc. stands at the forefront of genomic services, specializing in comprehensive genome sequencing and analysis. The company provides a broad spectrum of services, including whole genome sequencing, RNA sequencing, and microbiome analysis, catering to a diverse clientele comprising academic, governmental, and industrial institutions. Igenbio's expertise extends to delivering expert bioinformatics solutions and crucial regulatory filing support. Their advanced informatics platform, ERGO, significantly enhances their service delivery and underpins groundbreaking research. The company's robust offerings have earned the trust of leading institutions and Fortune 500 companies across sectors such as food and agriculture, bioremediation, and biodefense.
How much funding has Igenbio raised?
Igenbio has raised a total of $57K across 1 funding round:
Debt
$57K
Debt (2021): $57K with participation from PPP
What's next for Igenbio?
With the recent injection of substantial expansion capital, Igenbio is poised to accelerate its strategic initiatives. This funding is expected to bolster its bioinformatics platform, ERGO, and expand its service portfolio in genome sequencing and analysis. The company's focus on supporting academic, governmental, and industrial clients, coupled with its regulatory filing support capabilities, suggests a trajectory aimed at capturing a larger market share in the rapidly evolving genomics landscape. Future developments may include enhanced data analytics, broader application of microbiome analysis, and further integration of AI in bioinformatics solutions.
See full Igenbio company page
